This Cholesterol Drug Combination Might Lower Your Risk of Death, Study Finds
(ORLANDO) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often.
Results on the drug, Praluent, were announced Saturday at an American College of Cardiology conference in Florida. It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came out decades ago.
“It’s the ultimate outcome; it’s what matters to patients,” said study leader Dr. Philippe Gabriel Steg of Hospital Bichat i...
Source: TIME: Health - March 10, 2018 Category: Consumer Health News Authors: Marilyn Marchione / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news
The effect of local and systemic statin use as an adjunct to non-surgical and surgical periodontal therapy —A systematic review and meta-analysis
ConclusionsSignificant additional clinical and radiographic improvements are obtained after local, but not systemic, statin use as an adjunct to SRP in deep pockets associated with intrabony defects and seemingly with furcation defects; intrasurgical statin application seems similarly beneficial. Confirmation of these results, and especially of the effect size, from other research groups is warranted. (Source: Dental Technology Blog)
Source: Dental Technology Blog - October 20, 2017 Category: Dentistry Source Type: news
AstraZeneca ’ s Cancer Drug Trial Disappoints, Sending Shares Lower
The treatment had been expected to be a crucial driver of growth for the company as it faces more competition from generic pharmaceuticals. (Source: NYT Health)
Source: NYT Health - July 27, 2017 Category: Consumer Health News Authors: PRASHANT S. RAO Tags: Inventions and Patents Drugs (Pharmaceuticals) Crestor (Drug) AstraZeneca PLC Source Type: news
Heart Attack Survivors Often Fail to Take Statins
Most patients in a large study either took less of the lifesaving medicines than needed or stopped taking the drugs entirely within two years. (Source: NYT Health)
Source: NYT Health - April 24, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Heart Crestor (Drug) Statins (Cholesterol-Lowering Drugs) Source Type: news
Tackling a Decade of Change
There has never been a more exciting time to be in the pharmaceutical industry – if you like change, that is. While change is a constant in business, pharma has experienced unprecedented levels over the past decade, says Alistair Grenfell, President, North Europe, Middle East and Africa, at QuintilesIMS.“At a time when we are seeing a huge amount of innovation in our science and our pipeline – creating great excitement among the healthcare community – we need to acknowledge that our world has changed,” says Grenfell. “If you wind the clock back to 2005 and look at the top 10 selling medic ines, only one was a s...
Source: EyeForPharma - March 23, 2017 Category: Pharmaceuticals Authors: Hugh Gosling Source Type: news
Zocor (simvastatin) vs. Crestor (rosuvastatin)
Title: Zocor (simvastatin) vs. Crestor (rosuvastatin)Category: MedicationsCreated: 3/17/2017 12:00:00 AMLast Editorial Review: 3/17/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 17, 2017 Category: Cardiology Source Type: news
CardioBreak: Medicare Money for Micra; Stent Retriever Wins, Warnings; Crestor Switcheroo
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 13, 2017 Category: Cardiology Source Type: news
Health Care Special Report: KU doc finds cancer hope
After years of treating patients, researching cancer and testing treatments, Tomoo Iwakuma made the discovery of his lifetime: Statins, typically used to lower cholesterol levels, could treat some types of cancer.
An associate professor at the University of Kansas Medical Center, Iwakuma thinks that statins — such as brand names Crestor and Lipitor — could be used to treat 10 to 20 percent of cancer patients with a mutation in a tumor suppressor protein called p53. This mutation is found in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 3, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news
AstraZeneca hit by falling sales of bestsellers
Declines in Crestor and Nexium offset emerging markets growth (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 2, 2017 Category: Pharmaceuticals Source Type: news
Rosuvastatin Calcium Tablets (rosuvastatin calcium) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 12, 2017 Category: Drugs & Pharmacology Source Type: news
Patient With Chest Pain and Shortness of Breath Shows Standardized Treatment Doesn't Work for All Patients
John, a 65-year-old male, is sitting in a chair in the corner of the room as you and your partner enter his house. John tells you he's the only one home and called 9-1-1 because he can't breathe and his chest is killing him.
His skin is ashen and his breathing is rapid. You can palpate a weak irregular pulse and you note his skin is warm and diaphoretic. He describes his shortness of breath as increasing in severity over the last couple of hours with the chest discomfort. With a pulse oximetry reading of 78% on room air, you apply oxygen via a non-rebreathing mask.
Physical exam reveals bibasilar crackles on pulmonary ausc...
Source: JEMS Patient Care - December 30, 2016 Category: Emergency Medicine Authors: Dennis Edgerly, EMT-P Tags: Columns Patient Care Source Type: news
Statins may influence risk of Alzheimer ’s
Risk reduction depends on specific statin and ethnicity and sex of patient Related items fromOnMedica US doctor says FDA should have withdrawn rosuvastatin Detection bias may be behind memory loss with statins Statins might not cut colorectal cancer risk after all Major review clears statins US expert group updates statins recommendations (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 13, 2016 Category: UK Health Source Type: news
Pharma withheld faulty device info in rivaroxaban trial
Patients must live with uncertainty until concerns over key trial data are addressed Related items fromOnMedica Extending anticoagulation duration cuts risk of VTE recurrence Metformin lowers cardiac deaths better than other drugs US doctor says FDA should have withdrawn rosuvastatin NICE calls for safer use of controlled drugs BMJ questions trial evidence for rivaroxaban (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 28, 2016 Category: UK Health Source Type: news
Rosuvastatin Slows Progression of Atherosclerosis in HIV Rosuvastatin Slows Progression of Atherosclerosis in HIV
Find out what there is to know about the effect of rosuvastatin on subclinical atherosclerosis among HIV-infected individuals receiving antiretroviral therapy.AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - September 23, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
Crestor (Rosuvastatin Calcium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 1, 2016 Category: Drugs & Pharmacology Source Type: news
